Leadership changes Recent CEO transition at ASHS and appointment of new COO in 2024, followed by a CEO resignation in 2026. This presents an opening to engage with executive leadership changes to discuss strategic partnerships, renewals, or advocacy for refreshed technology and service agreements.

Strategic partnerships History of joint ventures and international expansion, including a Gamma Knife facility project in Guadalajara and partnerships with hospital networks. Opportunities exist to propose turnkey radiation therapy solutions, co-investment models, or regional expansion deals in Latin America and other markets.

Financing opportunities Past activity includes new loans and asset investments in cancer centers. Prospects for customized financing programs, equipment leasing, or sale-leaseback arrangements to help ASHS scale radiotherapy capabilities and accelerate project timelines.

Tech stack leverage ASHS uses modern web technologies and analytics tools, suggesting openness to digital modernization, telemedicine connectivity, and data-driven performance improvements. Solutions could include enhanced procurement portals, remote monitoring, and compliance-focused analytics for radiology services.

Public presence Regular attention to announcements and investor-facing news indicates a need for clear, repeatable communications and collateral. Sales conversations can emphasize value demonstrations, case studies, and scalable service offerings aligned with publicly shared milestones and upcoming showcases.